Mei Yu Phones & Addresses
-
1323 28Th St, Oakland, CA 94606
Business Records
Name / Title
Company / Classification
Phones & Addresses
Marketing Executive
Bechtel National, Inc.
Engineering Services
Engineering Services
50 Beale St, San Francisco, CA 94105
Treasurer
Befut Corporation
Office Manager
Sumui Kuo MD
Medical Doctor's Office · Pediatrician
Medical Doctor's Office · Pediatrician
728 Pacific Ave, San Francisco, CA 94133
(415) 393-6500
(415) 393-6500
716 Jackson Street, LLC
716 Jackson St, San Francisco, CA 94133
INTERNATIONAL TECH CORPORATION, LLC
President
Dick Lee Pastry Shop
Ret Pastry Shop
Ret Pastry Shop
777 Jackson St, San Francisco, CA 94133
716 Jackson St, San Francisco, CA 94133
(415) 397-0788, (415) 397-1236
716 Jackson St, San Francisco, CA 94133
(415) 397-0788, (415) 397-1236
President
C & S SEWING COMPANY, INC
1161 Msn St, San Francisco, CA 94103
President
ADAPNET TECHNOLOGY, INC
4700 Warm Spg Blvd STE 293, Fremont, CA 94539
Marketing Executive
Bechtel National, Inc.
Engineering Services
Engineering Services
50 Beale St, San Francisco, CA 94105
Publications
Us Patents
Hcv Genotype 3 Replicons
View pageUS Patent:
20130052633, Feb 28, 2013
Filed:
Jul 5, 2012
Appl. No.:
13/542551
Inventors:
Guofeng Cheng - Foster City CA, US
Hongmei Mo - Palo Alto CA, US
Simin Xu - Palo Alto CA, US
Mei Yu - San Francisco CA, US
Amoreena Corsa - San Francisco CA, US
Hongmei Mo - Palo Alto CA, US
Simin Xu - Palo Alto CA, US
Mei Yu - San Francisco CA, US
Amoreena Corsa - San Francisco CA, US
Assignee:
Gilead Sciences, Inc. - San Francisco CA
International Classification:
C12N 15/63
C12Q 1/70
C07K 14/18
C07K 16/10
C12N 15/40
C12N 5/09
C12Q 1/70
C07K 14/18
C07K 16/10
C12N 15/40
C12N 5/09
US Classification:
435 5, 4353201, 536 2372, 435370, 530350, 5303894
Abstract:
Replicons of genotype 3 of hepatitis C virus (HCV) are provided. These replicons contains adaptive mutations giving rise to the HCV's capability to replicate in vitro. Methods of preparing genotype 3 replicons and methods of using these replicons to screen antiviral agents are also provided.
Neuroprotective Effects Of Atf6
View pageUS Patent:
20060246037, Nov 2, 2006
Filed:
Jul 30, 2004
Appl. No.:
10/575457
Inventors:
Bryon Zhao - Millbrae CA, US
Mei Yu - San Francisco CA, US
Mei Yu - San Francisco CA, US
International Classification:
A61K 48/00
A61K 31/045
A61K 31/045
US Classification:
424093200, 514044000, 514738000
Abstract:
The present invention relates to methods for preventing cell death in a subject and the application of these methods for treating neurodegenerative diseases, such as Parkinson's disease, Alzheimer's disease, etc. In one embodiment of the invention, a method for preventing cell death may comprise effecting overexpression of an active form of ATF6 in the cell.
Methods Of Treating Hepatitis B Virus
View pageUS Patent:
20180042905, Feb 15, 2018
Filed:
Aug 29, 2017
Appl. No.:
15/689985
Inventors:
- Foster City CA, US
Todd Appleby - San Francisco CA, US
Gabriel Birkus - San Francisco CA, US
Guofeng Cheng - Foster City CA, US
David Dornan - Burlingame CA, US
Tetsuya Kobayashi - Pleasanton CA, US
Christopher Charles Mello - Sunnyvale CA, US
Uli Schmitz - Foster City CA, US
Madeleine Willkom - Foster City CA, US
Mei Yu - Foster City CA, US
Todd Appleby - San Francisco CA, US
Gabriel Birkus - San Francisco CA, US
Guofeng Cheng - Foster City CA, US
David Dornan - Burlingame CA, US
Tetsuya Kobayashi - Pleasanton CA, US
Christopher Charles Mello - Sunnyvale CA, US
Uli Schmitz - Foster City CA, US
Madeleine Willkom - Foster City CA, US
Mei Yu - Foster City CA, US
International Classification:
A61K 31/44
A61K 45/06
A61K 45/06
Abstract:
The present invention relates to novel methods of treating Hepatitis B Virus by administering a KDM5 inhibitor.
Methods Of Treating Hepatitis B Virus
View pageUS Patent:
20160303095, Oct 20, 2016
Filed:
Apr 13, 2016
Appl. No.:
15/098112
Inventors:
- Foster City CA, US
Todd Appleby - San Francisco CA, US
Gabriel Birkus - Dublin CA, US
Guofeng Cheng - Foster City CA, US
David Dornan - Burlingame CA, US
Tetsuya Kobayashi - Pleasanton CA, US
Christopher Charles Mello - Sunnyvale CA, US
Uli Schmitz - Foster City CA, US
Madeleine Willkom - Foster City CA, US
Mei Yu - Foster City CA, US
Todd Appleby - San Francisco CA, US
Gabriel Birkus - Dublin CA, US
Guofeng Cheng - Foster City CA, US
David Dornan - Burlingame CA, US
Tetsuya Kobayashi - Pleasanton CA, US
Christopher Charles Mello - Sunnyvale CA, US
Uli Schmitz - Foster City CA, US
Madeleine Willkom - Foster City CA, US
Mei Yu - Foster City CA, US
International Classification:
A61K 31/44
A61K 45/06
A61K 45/06
Abstract:
The present invention relates to novel methods of treating Hepatitis B Virus by administering a KDM5 inhibitor.
Daily Task Tools That Interface With Backend Systems
View pageUS Patent:
20150058752, Feb 26, 2015
Filed:
Sep 19, 2013
Appl. No.:
14/032064
Inventors:
Ingrid Bernaudin - Palo Alto CA, US
Michael Dandan - San Mateo CA, US
Steve Zyszkiewicz - San Bruno CA, US
Frank Wang - Santa Clara CA, US
Mei Yu - Palo Alto CA, US
Vidya Viswanath - San Jose CA, US
Michael Dandan - San Mateo CA, US
Steve Zyszkiewicz - San Bruno CA, US
Frank Wang - Santa Clara CA, US
Mei Yu - Palo Alto CA, US
Vidya Viswanath - San Jose CA, US
Assignee:
SUCCESSFACTORS, INC. - South San Francisco US
International Classification:
H04L 29/06
G06F 3/0488
G06F 3/0482
G06F 3/0488
G06F 3/0482
US Classification:
715753
Abstract:
In one embodiment, an improved computer based daily task tool is provided that interfaces with backend systems to leverage the stored information and/or processing capabilities of backend systems to provide better information and more effective task tool functionality.
Systems And Methods For Secure Storage On A Mobile Device
View pageUS Patent:
20140337638, Nov 13, 2014
Filed:
May 10, 2013
Appl. No.:
13/892048
Inventors:
- South San Francisco CA, US
Mei Yu - Palo Alto CA, US
Mei Yu - Palo Alto CA, US
Assignee:
SUCCESSFACTORS - South San Francisco CA
International Classification:
G06F 21/60
US Classification:
713189
Abstract:
In one embodiment the present invention includes a computer-implemented method for a mobile device. An application security status is detected. When the application security status is active an application passcode is required to access functionality of a mobile application operating on the mobile device. A first encryption of data associated with the mobile application is performed, where the first encryption uses a first encryption key when the application security status is active, and the first encryption uses a second encryption key when the application security status is not active. A mobile device passcode status is detected. When the mobile device passcode status is active a mobile device passcode is required to access functionality of the mobile computing device. A second encryption of the data is performed when the mobile device passcode status is active, where the second encryption uses a third encryption key.
Hcv Genotype 6 Replicons
View pageUS Patent:
20140134604, May 15, 2014
Filed:
Nov 6, 2013
Appl. No.:
14/073488
Inventors:
- Foster City CA, US
Betty Peng - London, GB
Mei Yu - San Francisco CA, US
Betty Peng - London, GB
Mei Yu - San Francisco CA, US
International Classification:
C12Q 1/70
C07K 16/10
C07K 14/005
C07K 16/10
C07K 14/005
US Classification:
435 5, 536 2372, 435366, 530350, 5303894, 536 2433, 536 2432, 536 253
Abstract:
Replicons of genotype 6 hepatitis C virus (HCV) are provided. These replicons contain adaptive mutations giving rise to the HCV's capability to replicate in vitro. Methods of preparing genotype 6 replicons and methods of using these replicons to screen antiviral agents are also provided.